Renalys Pharma Announces Positive Phase 3 Results for Sparsentan in Japanese Patients with IgA Nephropathy TOKYO, Nov. 26, 2025 /PRNewswire/ — Renalys Pharma, Inc. (Headquarters: chuo-ku, Tokyo; “Renalys”) today announced …
Tag: